"Die Klinikum Vest GmbH ist mit 483 Betten im Behandlungszentrum Knappschaftskrankenhaus Recklinghausen und 285 Betten im Behandlungszentrum Paracelsus-Klinik Marl ein Klinikum der Schwerpunktversorgung und akademisches Lehrkrankenhaus der Ruhr-Universität Bochum. Es ist der zentrale Baustein des „proGesund“-Netzwerkes der Knappschaft Bahn See sowie weiterer Ärztenetze. Circa 1.900 Mitarbeiter versorgen mehr als 31.000 stationäre und 82.500 ambulante Patienten und Patientinnen in unseren Fachkliniken. Wir wünschen Ihnen einen angenehmen Aufenthalt in unserem Hause und eine baldige Genesung."

During the past decade, Klinikum Vest GmbH conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Vest GmbH" #1 sponsor was "Ruhr University of Bochum" with 2 trials, followed by "Spirig Pharma Ltd." with 2 trials sponsored, "IHF GmbH - Institut für Herzinfarktforschung" with 1 trials sponsored, "Jena University Hospital" with 1 trials sponsored and "Microvention-Terumo, Inc." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Vest GmbH" #1 collaborator was "European Commission" with 1 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials as a collaborator, "Medtronic" with 1 trials as a collaborator and "Swiss National Fund for Scientific Research" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Vest GmbH" are "Actinic Keratosis" (2 trials), "Actinic Keratoses" (1 trials), "Acute Ischemic Stroke" (1 trials), "Acute Myeloid Leukemia (AML)" (1 trials) and "Anastomotic Leak" (1 trials). Many other conditions were trialed in "Klinikum Vest GmbH" in a lesser frequency.

Most popular intervention types in "Klinikum Vest GmbH" are "Procedure" (5 trials), "Device" (4 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Aktilite® Galderma" (1 trials), "CardioMEMSTM HF sensor - pulmonary artery pressure measurement" (1 trials), "Cryosurgery" (1 trials), "Daylight photodynamic therapy using Methylaminolevulinate (MAL)" (1 trials) and "Endoscopic negative pressure therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Vest GmbH" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Vest GmbH". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Klinikum Vest GmbH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Vest GmbH, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".

Klinikum Vest GmbH has several departments that took part in Clinical trials: "Neurologische Klinik Knappschafts - krankenhause" - 2 trials, "KLINIKUM VEST GMBH Knappschaftskrankenhaus Klinik für Radiologie und Neuroradiologie" - 2 trials